Home  >  Products  >  MEF2B (myocyte enhancer factor 2B) Blocking Peptide (the N terminal of protein) (100ug)
MEF2B (myocyte enhancer factor 2B) Blocking Peptide (the N terminal of protein) (100ug)

MEF2B (myocyte enhancer factor 2B) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-MEF2B antibody (Catalogue #: ARP38696_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP38696
Size: 100 ug
Weight: 39kDa
Gene: 4207
Format: Lyophilized powder
Target: This gene represents numerous read-through transcripts that span geneID:729991 and 100271849. Many read-through transcripts are predicted to be nonsense-mediated decay (NMD) candidates, and are thought to be non-coding. Some transcripts are predicted to be capable of translation reinitation at a downstream AUG, resulting in expression of at least one isoform of myocyte enhancer factor 2B (MEF2B) from this read-through locus.
Alternative names: FLJ32599; FLJ46391; RSRFR2
See Full Product Listings >